Position in CABR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$44,602
New position
Shares Held
35,970
first reported quarter
Ownership
0.347%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 10 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $845,206,958 across 34 Drug Manufacturers - Specialty & Generic names. CABR ranks #32 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
340,275 | $184,371,197 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
3,316,358 | $136,070,166 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
553,068 | $93,214,076 | |
| 4 | VTRS |
Viatris Inc
|
5,658,439 | $89,856,006 | |
| 5 | ZTS |
Zoetis Inc.
|
912,367 | $65,562,688 | |
| 6 | ALKS |
Alkermes plc.
|
1,170,242 | $61,320,679 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
2,950,225 | $52,986,040 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
2,844,583 | $41,218,006 |
All Filings in CABR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,602 | 35,970 | Shares | Defined | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||